RG33 is a short peptide motif enriched in arginine and glycine residues, imparting flexibility and strong electrostatic character. The sequence serves as a minimal model for examining nucleic-acid binding and protein-contact interfaces. Researchers analyze its conformational landscape by spectroscopy and simulation. Applications include cell-penetrating motif studies, RNA-binding research, and peptide-design efforts.
CAT No: R2773
RG33 is a synthetic peptide compound designed for advanced biochemical research, particularly within the fields of signal transduction and receptor biology. As a short, sequence-specific peptide, RG33 is engineered to interact with defined protein targets, making it a valuable tool in mechanistic studies of protein-protein interactions. Its structural attributes enable researchers to mimic or disrupt native biological processes, which is crucial for elucidating molecular pathways and validating biological hypotheses in a controlled laboratory setting. The compound's stability and sequence fidelity further enhance its utility in a variety of experimental systems, including in vitro assays and cellular models.
Peptide-protein interaction studies: RG33 serves as a precise molecular probe for dissecting the dynamics of peptide-protein interactions. By incorporating this peptide into binding assays, researchers can systematically investigate the affinity and specificity of target proteins, such as receptors, enzymes, or scaffolding molecules. This application is particularly valuable for characterizing interaction domains, mapping binding sites, and quantifying kinetic parameters, all of which are fundamental for understanding cellular signaling mechanisms and regulatory networks.
Signal transduction research: In studies focused on cellular signaling, RG33 can be used to modulate or mimic endogenous peptide ligands, allowing for the analysis of downstream effects within signaling cascades. By applying the peptide to cultured cells or biochemical systems, investigators can probe the activation or inhibition of specific pathways, such as kinase cascades or G-protein coupled receptor signaling. This approach aids in delineating the roles of individual signaling components and supports the identification of potential regulatory checkpoints within complex biological systems.
Peptide inhibitor screening: The defined sequence of RG33 makes it an excellent candidate for use in high-throughput screening platforms aimed at identifying small molecules or biologics that modulate peptide-mediated interactions. By serving as a competitive substrate or binding partner, the peptide enables the evaluation of potential inhibitors or enhancers, facilitating the discovery of new research tools and molecular probes. Such screens are essential for expanding the toolkit available for functional studies and for validating the specificity of candidate compounds.
Structure-activity relationship (SAR) analysis: Researchers can leverage RG33 in systematic SAR studies to assess how sequence modifications influence biological activity. By introducing amino acid substitutions, truncations, or modifications to the parent peptide, it is possible to evaluate changes in binding affinity, stability, or functional efficacy. These experiments provide critical insights into the determinants of peptide activity and inform the rational design of optimized analogs for future research applications.
Peptide synthesis validation: RG33 is frequently employed as a reference standard or positive control in peptide synthesis workflows. Its well-characterized sequence and predictable behavior make it suitable for validating synthetic protocols, optimizing purification procedures, and calibrating analytical equipment such as HPLC or mass spectrometry systems. Utilizing the peptide in these contexts ensures the reliability of peptide production processes and enhances the reproducibility of experimental outcomes across research laboratories.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More